Biopharmaceutical company developing prophylactic vaccines and immunotherapeutics for infectious diseases and cancer
Biopharmaceutical company developing prophylactic vaccines and immunotherapeutics for infectious diseases and cancer. Its virus-like particle platforms, including enveloped VLP (eVLP) and mRNA-launched eVLP (MLE), are designed to mimic natural viral presentation and stimulate immune responses. Pipeline targets include hepatitis B, COVID-19 and other coronaviruses, CMV, Zika, and glioblastoma.